Copyright
©The Author(s) 2003.
World J Gastroenterol. Dec 15, 2003; 9(12): 2698-2700
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2698
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2698
Table 1 Comparison of study and control groups
| Study group | Control group | |
| Case number | 20 | 21 |
| Median Age (min-max) (year) | 23 (15-48) | 24 (16-52) |
| Genus (M/F) | 12/8 | 16/5 |
| ALT (U/L) | 1730 ± 628 | 2129 ± 1278 |
| AST (U/L) | 987 ± 545 | 1397 ± 1002 |
| ALP (U/L) | 488 ± 201 | 410 ± 149 |
| Total bilirubin (mg/dL) | 7.75 ± 4.36 | 10.1 ± 3.04 |
| Direct bilirubin (mg/dL) | 5.29 ± 3.14 | 7.17 ± 3.26 |
| Activity of prothrombin (%) | 72.6 ± 22.7 | 74.1 ± 18.9 |
| Albumin (g/dL) | 3.95 ± 0.54 | 3.98 ± 0.40 |
| Type of hepatitis (A/B) | 4/16 | 5/16 |
| Time consumption for | 19.7 ± 6.9 | 20.4 ± 6.5 |
| ALT < 100 U/L | ||
| Time consumption for total | 13.7 ± 8.5 | 16.9 ± 7.8 |
| bilirubin < 2 mg/dl |
- Citation: Gunduz H, Karabay O, Tamer A, Özaras R, Mert A, Tabak &F. N-acetyl cysteine therapy in acute viral hepatitis. World J Gastroenterol 2003; 9(12): 2698-2700
- URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2698.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i12.2698